BioCentury | Mar 25, 2020
Finance

March 24 Quick Takes: Apexigen brings series C to $123M; plus Nanjing F&S, FCA and Asieris

Apexigen boosts series C with $65M extension   Apexigen Inc. added $65 million to its 2018 series C, bringing the round to $123 million. The extension was led by Decheng Capital and new investor Oceanpine...
BC Week In Review | Jan 5, 2018
Financial News

Asieris raises series B round

Asieris Pharmaceuticals Co. Ltd. (Taizhou, China) said on Dec. 27, 2017, that it raised RMB110-RMB120 million ($16.8-$18.3 million) in a series B round led by Lapam Capital. Fellow new investors Kaitai Capital and Zhongguancun Qihang...
BC Extra | Dec 29, 2017
Financial News

Asieris raises series B round

Asieris Pharmaceuticals Co. Ltd. (Taizhou, China) said it raised RMB110-RMB120 million ($16.8-$18.3 million) in a series B round led by Lapam Capital. Fellow new investors Kaitai Capital and Zhongguancun Qihang Industry Fund also participated, as...
Items per page:
1 - 3 of 3